In the interpretation of thrombophilia markers and gene polymorphisms using logistic regression analysis in the patient and control groups, no statistically significant risk increase was observed for markers other than APOA1 rs5069 gene polymorphism. The gene discussed is APOA1; the disease is Rare hereditary thrombophilia.